Literature DB >> 15623715

Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.

S Kedia1, E Moro, M Tagliati, A E Lang, R Kumar.   

Abstract

The authors systematically studied the emergence of restless legs syndrome (RLS) after subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson disease (PD). Postoperatively, 11 of 195 patients with STN DBS reported new problematic symptoms of RLS. The mean reduction in antiparkinsonian medication was 74%. The mean RLS score at diagnosis was 15 (+/-5.9) of a possible 24 points and after symptomatic drug therapy 4.3 (+/-3.1) points. Reduction of antiparkinsonian medication during STN DBS may unmask symptoms of RLS and complicate therapy of both RLS and PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623715     DOI: 10.1212/01.wnl.0000147288.26029.b8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Authors:  P N Margariti; L G Astrakas; S G Tsouli; G M Hadjigeorgiou; S Konitsiotis; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 2.  Deep brain stimulation: current and future clinical applications.

Authors:  Mark K Lyons
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

Review 3.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

Review 4.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

Review 5.  Restless legs syndrome and Parkinson's disease: is there an etiologic link?

Authors:  Eng-King Tan
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 6.  Management of sleep disorders in Parkinson's disease and multiple system atrophy.

Authors:  Aleksandar Videnovic
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

Review 7.  Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide.

Authors:  Christian R Baumann
Journal:  J Neural Transm (Vienna)       Date:  2019-06-29       Impact factor: 3.575

8.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

9.  Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology.

Authors:  Laura C Horton; Matthew P Frosch; Mark G Vangel; Carol Weigel-DiFranco; Eliot L Berson; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

Review 10.  Treatment of the sleep disorders associated with Parkinson's disease.

Authors:  Lynn Marie Trotti; Donald L Bliwise
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.